Document is current
Any future updates will be listed below
-
Authors
Verweij, EJT
Lopriore, Enrico
Fitzgibbon, Marie https://orcid.org/0009-0008-7828-4687
Noack, Jenny https://orcid.org/0009-0008-9917-8592
Wilke, Thomas
Noel, Wim
van Klink, Jeanine
-
Funding
Funding for this research was provided by:
Janssen Pharmaceutica NV
Janssen Pharmaceuticals
- License Information
-
More Information
Article History
Received: 6 June 2024
Revised: 2 March 2025
Accepted: 10 July 2025
First Online: 19 September 2025
Competing interests
: The authors declare the following conflict of interests: Author: Declaration of competing interest: E.J.T. Verweij: EJTV is an investigator in studies sponsored by Janssen. No personal consultancies are paid. Enrico Lopriore: EL received consulting fees for membership of steering committees and advisory boards for clinical studies from Momenta Pharmaceuticals, Inc., and Janssen Pharmaceuticals, Inc. Marie Fitzgibbon: MF is an employee of Janssen Pharmaceutica NV. Jenny Noack: JN participated in this study as staff member of Cytel; the work of Cytel in this study was financed by Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium. Thomas Wilke: TW has worked for different healthcare consultancies that did projects for most of the top 50 pharmaceutical companies in the past. Wim Noel: WN is an employee of Janssen Pharmaceutica NV. Jeanine van Klink: JVK is a consultant on real-world studies sponsored by Janssen. No personal consultancies are paid.
: As this study was a retrospective, non-interventional study, no ethic declaration was required.
